Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Does the Forecast Indicate for the Immunohematology Market From 2025 to 2029?

In recent times, the immunohematology market has demonstrated consistent growth. The market value is anticipated to rise from $2.46 billion in 2024 to $2.55 billion in 2025, corresponding to a compound annual growth rate (CAGR) of 3.6%. Factors contributing to growth during the historical period include advancements in blood transfusion technologies, the widespread occurrence of blood disorders, the proliferation of blood banks, government efforts towards ensuring blood safety, a rise in surgical procedures, and a heightened awareness about risks related to transfusion.

In the coming years, expect to see a robust expansion in the immunohematology market. It’s predicted to reach $3.17 billion by 2029, boasting a compound annual growth rate (CAGR) of 5.7%. This projected growth during the forecasted period is linked to the rising popularity of point-of-care testing, the emergence of innovative blood products, the development of healthcare infrastructures, the utilization of genetic testing for blood compatibility, and regulatory assistance for blood safety. Key trends for this forecasted span include automation and high-throughput systems, advances in molecular blood typing methods, techniques for antibody detection, the implementation of patient blood management programs, as well as the incorporation of AI in analysis and telemedicine.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10295&type=smp

What Elements Are Contributing To Growth In The Immunohematology Market?

The increase in the occurrence rate of blood disorders is projected to steer the escalation of the immunohematology market in the future. Blood disorders are a varied group of ailments that influence blood and its components like red blood cells, white blood cells, platelets, and plasma. Immunohematology plays a critical role in safeguarding effective and safe blood transfusions, as it aids in avoiding transfusion reactions resulting from mismatched blood types or the existence of antibodies in the recipient’s blood. Techniques in immunohematology are employed in diagnosing and treating ailments related to the immune system that could potentially affect the blood system. For instance, Cancer Research UK, a research organization based in the UK, anticipates the mean rate of new leukemia cases due to blood disorders in the UK to ascend from nearly 12,400 cases in 2023-2025 to approximately 14,500 cases in 2038-2040. Hence, the increasing occurrence rate of blood disorders is stimulating the expansion of the immunohematology market.

Which Segments Are Detailed In The Global Immunohematology Market Report?

The immunohematology market covered in this report is segmented –

1) By Product: Analyzers And Systems, Reagents

2) By Technology: Biochips, Erythrocyte-Magnetized Technology (Met), Gel Cards, Microplates, Polymerase Chain Reaction (PCR)

3) By Disease: Blood-Related Diseases, HIV, Hepatitis

4) By Application: Pretransfusion Testing, Investigation Of Immune Hemolysis, Perinatal Testing, Blood Group Phenotyping, Leucocyte And Platelet Serology

5) By End User: Blood Banks, Diagnostic And Reference Laboratories, Hospitals, Academic And Research Institutes

Subsegments:

1) By Analyzers And Systems: Blood Typing Analyzers, Cross-Matching Analyzers, Gel Card Systems

2) By Reagents: Blood Grouping Reagents, Antisera, Control Serum

Which Emerging Trends And Strategic Shifts Are Shaping The Immunohematology Market?

Leading firms in the immunohematology market, such as Grifols, S.A., are making strides in the creation and implementation of advanced diagnostic techniques like soluble recombinant proteins that tackle the challenges posed by cancer therapy drug daratumumab. Soluble recombinant proteins are engineered via recombinant DNA methodologies to remain stable and effective in a host cell or solution, making them suitable for research and treatment purposes. Back in November 2023, Grifols, based in Spain, introduced Grifols sCD38 solution, the first of its kind soluble recombinant protein. It was specifically devised to mitigate the complications that daratumumab causes in essential blood transfusion compatibility examinations. The solution, tailor-made for individuals with multiple myeloma, stops daratumumab from coupling with CD38 proteins on red blood cells thus leading to more accurate pre-transfusion result. Grifols sCD38 boosts blood transfusion processes and reduces time lags in provision of paramount transfusions by streamlining the entire procedure, including screening, identification, and crossmatching.

Who Are The Key Contributors To Growth In The Immunohematology Market?

Major companies operating in the immunohematology market include Ortho Clinical Diagnostics Inc., Immunocor Inc., Abbott Laboratories, Siemens Healthineers AG, Grifols S.A., Beckman Coulter Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Merck Co. & KGaA, Bio-Rad Laboratories, Sysmex Corporation, Danaher Corporation, Biosystems S.A., Roche Holdings AG, Mindray Medical International Limited, F.Hoffmann La-Roche Ltd., Biotest AG, Cardinal Health Inc., Quotient Limited, DiaSorin S.p.A., Lorne Laboratories Ltd., Biokit S.A., Avox Technologies, Diagnostic Automation/Cortez Diagnostics Inc., Inno-train Diagnostik GmbH, Drucker Diagnostics Inc., Immundia Diagnostics Pvt. Ltd.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report

Which Region Is Projected To Lead The Immunohematology Market By 2025?

North America was the largest region in the immunohematology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global immunohematology market during the forecast period. The regions covered in the immunohematology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10295&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model